CN Patent

CN111166748B — 吡非尼酮在制备促血管生成药物中的应用

Assigned to Shenzhen Institute of Advanced Technology of CAS · Expires 2022-06-21 · 4y expired

What this patent protects

本发明提供了一种吡非尼酮在制备促血管生成药物中的应用，所述吡非尼酮的化学结构式如下式1所示，或者为下式1所示的盐所述吡非尼酮在一定浓度下可能通过促进MMP‑2和P‑SRC表达，具有显著促进人脐静脉内皮细胞(EA.hy926)的成血管作用。

USPTO Abstract

本发明提供了一种吡非尼酮在制备促血管生成药物中的应用，所述吡非尼酮的化学结构式如下式1所示，或者为下式1所示的盐所述吡非尼酮在一定浓度下可能通过促进MMP‑2和P‑SRC表达，具有显著促进人脐静脉内皮细胞(EA.hy926)的成血管作用。

Drugs covered by this patent

Patent Metadata

Patent number: CN111166748B
Jurisdiction: CN
Classification: —
Expires: 2022-06-21
Drug substance claim: No
Drug product claim: No
Assignee: Shenzhen Institute of Advanced Technology of CAS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.